Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01860378 · ClinicalTrials.gov registry record · Early Phase 1
Vouchers to Promote Tdap Vaccination
A Early Phase 1 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 149
- Enrollment target
NCT01860378 is a Early Phase 1 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 149 participants.
The verdict
NCT01860378, a Early Phase 1 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 149 participants
- Enrollment target
Study Summary
This study is a small-scale randomized, placebo-controlled factorial trial of two interventions to increase Tetanus, diphtheria and acellular pertussis (Tdap) immunization rates among infant caregivers. Specifically, the trial will compare a full cost vs. $5 Tdap voucher with or without an educational video.
Interventions
- OTHER Full price
- OTHER $5 off
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01860378
The ClinicalTrials.gov registry entry for NCT01860378 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Full price is the first listed.
NCT01860378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01860378 about?
NCT01860378 is a clinical study titled "Vouchers to Promote Tdap Vaccination". This study is a small-scale randomized, placebo-controlled factorial trial of two interventions to increase Tetanus, diphtheria and acellular pertussis (Tdap) immunization rates among infant caregivers. Specifically, the trial will compare a full cost vs. $5 Tdap voucher with or without an education...
What is the current status of trial NCT01860378?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 149 participants. The study started on 2013-07. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01860378?
The interventions under investigation include: Full price (OTHER), $5 off (OTHER).
Who is sponsoring clinical trial NCT01860378?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.